Gastrointestinal Cancer News

The FDA expanded the clearance of a cryoablation technology platform for the treatment of cancerous and benign tumors of the kidney; liver; and ear, nose or throat, according to a press release from the product’s manufacturer.

Proton chemoradiotherapy appeared associated with a substantial reduction in acute adverse events that caused unplanned hospitalizations compared with traditional photon chemoradiotherapy among adults with locally advanced cancer, according to results of a retrospective study published in JAMA Oncology.

The FDA granted fast track designation to infigratinib for first-line treatment of unresectable advanced or metastatic cholangiocarcinoma who harbor FGFR2 gene fusions or translocations, according to the agent’s manufacturer.

In 2018, infections were the cause of 13% of all new cancer diagnoses, totaling 2.2 million new cases worldwide, although these totals do not include nonmelanoma skin cancers, according to findings published in The Lancet Global Health.

An ongoing proof-of-concept clinical trial is underway to assess the use of a novel T-cell therapy for the treatment of advanced hepatocellular carcinoma.

Black patients with cancer appeared to be at a higher risk for cancer-associated venous thromboembolism than patients of other races, according to results of a retrospective study published in American Journal of Clinical Oncology.

The FDA approved olaparib as maintenance treatment for adults with deleterious or suspected deleterious germline BRCA-mutated metastatic pancreatic cancer, according to a press release from the drug’s manufacturer.

The FDA granted orphan drug designation to the antibody-drug conjugate OBI-999 for the treatment of pancreatic cancer, according to a press release from the agent’s manufacturer.

Among patients who underwent PCI, those with cancer had elevated risks for cardiac mortality and bleeding, researchers reported in JACC: CardioOncology.

Historically, the goal of cancer treatment has been to destroy as many cancer cells as possible through chemotherapy or radiation.